3,4-Methylenedioxymethamphetamine (MDMA) Intoxication in an Infant Chronically Exposed to Cocaine
Oscar García-algar, Nuria L Pez, M. Á. Bonet, Manuela Pellegrini, Emilia Marchei, Simona Pichini
Therapeutic Drug Monitoring July 22, 2005 DOI: 10.1097/01.ftd.0000166041.97524.50 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Case study Case report Peer reviewed |
|---|---|
| Sample size | 1 |
| Population | Infant |
| Intervention | benzodiazepines |
| Duration | 1 day |
| Topics | MDMA |
| Keywords | Ingestion Urine Hair analysis Discontinuation Drug Methamphetamine Accidental Hallucinogen Anesthesia Pharmacology |
| Citations | 39 |
| Key findings | Accidental ingestion of MDMA and chronic cocaine exposure were detected in an infant, with symptoms resolving after benzodiazepine treatment. |
Abstract
Accidental ingestion of 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) was detected in an infant admitted at the Pediatric Emergency Department by drug testing in urine. Concentrations of MDMA and its principal metabolite 4-hydroxy-3-methoxymethamphetamine (HMMA) in the infant's hydrolyzed urine were 11.7 mg/L and 34.4 mg/L, respectively. Apparent febrile convulsions and cardiovascular side effects resolved within 1 day after treatment with benzodiazepines. Chronic exposure to cocaine was evidenced by segmental hair analysis. Continuous maternal denial of the presence of any drug in the household made diagnosis of accidental ingestion of MDMA and chronic exposure to cocaine problematic. Periodic clinical and laboratory follow-ups were requested to check eventual long-term effects of exposure to illicit drugs and discontinuation of the child from exposure to dangerous environments.
Comparable studies
Other case reports and case series on MDMA, most cited first.
| Study | Year | Design | Participants |
|---|---|---|---|
| 'Eve' and 'Ecstasy'. A report of five deaths associated with the use of MDEA and MDMA Individuals whose deaths were associated with MDMA or MDEA use | 1987 | Case series | n = 5 |
| Pathology of deaths associated with "ecstasy" and "eve" misuse. Young white men aged 20 to 25 who died after using ring-substituted amphetamines (MDMA... | 1996 | Case series | n = 7 |
| 'Eve' and 'Ecstasy' Individuals who died after using MDMA or MDEA | 1987 | Case series | n = 5 |
| A Method of Conducting Therapeutic Sessions with MDMA Clients with clear therapeutic purpose, excluding those with serious functional... | 1998 | Case study | n = 2 |
| Diversity of Psychopathology Associated with use of 3,4-Methylenedioxymethamphetamine (‘Ecstasy’) Psychiatric patients presenting between 1990 and 1992 whose symptoms developed in the... | 1994 | Case series | n = 13 |
Citations in the library
Cited by 2
Cites 5
- Human Pharmacology of MDMA Therapeutic Drug Monitoring March 19, 2004
- 'Eve' and 'Ecstasy'. A report of five deaths associated with the use of MDEA and MDMA JAMA March 27, 1987
- 'Eve' and 'Ecstasy' JAMA March 27, 1987
- Use of MDMA and Other Illicit Drugs by Young Adult Males in Northern Spain European Addiction Research 2002
- Adverse reactions with 3,4-methylenedioxymethamphetamine (MDMA; 'ecstasy'). Drug safety August 1996